| 注册
首页|期刊导航|中国临床药理学杂志|多柔吡星注射剂治疗带状疱疹后遗神经痛的临床研究

多柔吡星注射剂治疗带状疱疹后遗神经痛的临床研究

王一雄 许宝珠 颜景佳 江长城 庄渊钊 周建英

中国临床药理学杂志2018,Vol.34Issue(7):774-776,3.
中国临床药理学杂志2018,Vol.34Issue(7):774-776,3.DOI:10.13699/j.cnki.1001-6821.2018.07.011

多柔吡星注射剂治疗带状疱疹后遗神经痛的临床研究

Clinical trial of doxorubicin injection in the treatment of post-herpetic neuralgia

王一雄 1许宝珠 2颜景佳 1江长城 1庄渊钊 1周建英1

作者信息

  • 1. 福建医科大学附属泉州第一医院麻醉科,福建泉州362000
  • 2. 福建医科大学附属第二医院介入室,福建泉州362000
  • 折叠

摘要

Abstract

Objective To observe the clinical efficacy and safety of doxorubicin injection in the treatment of post-herpetic neuralgia.Methods One hundred and four patients with post-herpetic neuralgia were randomly divided into control and treatment groups with 52 cases per group.Control group was given pulse radiofrequency therapy with 3 min per time,twice a week.Treatment group was given doxorubicin 10 mg per time,once two weeks,intervertebral foramen injection.Two groups were treated for 4 weeks.The clinical efficacy,visual analogue scale (VAS) scores,the levels of serum interleukin-6 (IL-6) and IL-10,and adverse drug reactions were compared between two groups.Results After treatment,the total effective rates of treatment and control groups were 86.54% (45 cases/52 cases) and 69.23% (36 cases/52 cases) with significant difference (P < 0.05).After treatment,the main indexes in treatment and control groups were compared:IL-6 were (174.83±23.72) and (321.65 ±45.82) pg · mL-1,IL-10 were (183.46 ±28.11) and (164.67 ±21.31) μg · mL-1,VAS were (2.32 ±0.65) and (3.51 ±0.84) score,the differences were statistically significant (all P < 0.05).The adverse drug reactions in treatment group were skin numbness in block area and palpitation,and no adverse drug reactions occurred in control group.The incidences of adverse drug reactions in treatment and control groups were 5.77% and 0 without significant difference (P > 0.05).Conclusion Doxorubicin injection has a definitive clinical efficacy in the treatment of post-herpetic neuralgia,which can significantly balance the inflammatory factors,improve the pain,without increasing the incidence of adverse drug reactions.

关键词

多柔吡星注射剂/带状疱疹后遗神经痛/安全性

Key words

doxorubicin injection/post-herpetic neuralgia/safety

分类

医药卫生

引用本文复制引用

王一雄,许宝珠,颜景佳,江长城,庄渊钊,周建英..多柔吡星注射剂治疗带状疱疹后遗神经痛的临床研究[J].中国临床药理学杂志,2018,34(7):774-776,3.

基金项目

泉州市科技局技术研究与开发基金资助项目(20132157) (20132157)

中国临床药理学杂志

OA北大核心CSCDCSTPCD

1001-6821

访问量1
|
下载量0
段落导航相关论文